Patient-specific stem cells and personalized gene therapy

10 julio 2014

Researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss. The approach, the first of its kind, takes advantage of induced pluripotent stem cell technology to transform skin cells into retinal cells, which are then used as a patient-specific model for disease study and preclinical testing.